Evidence map›Paper›PMID 32647868›Full record

ArticleCardiovascular research2021

The glycocalyx core protein Glypican 1 protects vessel wall endothelial cells from stiffness-mediated dysfunction and disease.

Marwa Mahmoud, Mariya Mayer, Limary M Cancel, Anne Marie Bartosch, Rick Mathews, John M Tarbell

Open access · greenAbstract readComparative Study
In one paragraph

Article in Cardiovascular research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Heparan Sulfates Regulate Vascular Reactivity in Syndecan 1 Knockout Mice.International journal of molecular sciences · 2026
    Article
  6. Endothelial Surface Glycocalyx in Vascular Functions and Diseases.Advances in experimental medicine and biology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Marwa MahmoudDepartment of Biomedical Engineering, The City College of New York, New York, NY, USA.ORCID 0000-0002-6812-4240
Mariya MayerDepartment of Biomedical Engineering, The City College of New York, New York, NY, USA.
Limary M CancelDepartment of Biomedical Engineering, The City College of New York, New York, NY, USA.
Anne Marie BartoschDepartment of Pathology and Cell Biology, Columbia University, New York, NY, USA.ORCID 0000-0003-0031-6024
Rick MathewsOregon Health & Science University, School of Medicine, Portland, OR, USA.ORCID 0000-0003-2723-5646
John M TarbellDepartment of Biomedical Engineering, The City College of New York, New York, NY, USA.ORCID 0000-0001-6696-0272
City College of New York · USColumbia University · USOregon Health & Science University · US

Funding

The Endothelial Glycocalyx: Its Structure and Function and as a MechanotransducerR01HL094889 · NHLBI · CITY COLLEGE OF NEW YORK · PI TARBELL, JOHN M · 2010 to 2014
$2.4M
Targeting glycocalyx-mediated mechanisms of tumor metastasisR01CA204949 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MUNN, LANCE L., TARBELL, JOHN M · 2017 to 2021
$2.3M
The role of the glycocalyx in matrix stiffness-mediated vascular diseaseF32HL145913 · NHLBI · CITY COLLEGE OF NEW YORK · PI MAHMOUD, MARWA · 2019 to 2021
$154k
NCI NIH HHS R01 CA204949NHLBI NIH HHS F32 HL145913NHLBI NIH HHS R01 HL094889
6 · The paper itself

Abstract

aimsArterial stiffness is an underlying risk factor and a hallmark of cardiovascular diseases. The endothelial cell (EC) glycocalyx is a glycan rich surface layer that plays a key role in protecting against EC dysfunction and vascular disease. However, the mechanisms by which arterial stiffness promotes EC dysfunction and vascular disease are not fully understood, and whether the mechanism involves the protective endothelial glycocalyx is yet to be determined. We hypothesized that endothelial glycocalyx protects the endothelial cells lining the vascular wall from dysfunction and disease in response to arterial stiffness. METHODS AND

resultsCells cultured on polyacrylamide (PA) gels of substrate stiffness 10 kPa (mimicking the subendothelial stiffness of aged, unhealthy arteries) showed a significant inhibition of glycocalyx expression compared to cells cultured on softer PA gels (2.5 kPa, mimicking the subendothelial stiffness of young, healthy arteries). Specifically, gene and protein analyses revealed that a glycocalyx core protein Glypican 1 was inhibited in cells cultured on stiff PA gels. These cells had enhanced endothelial cell dysfunction as determined by enhanced cell inflammation (enhanced inflammatory gene expression, monocyte adhesion, and inhibited nitric oxide expression), proliferation, and EndMT. Removal of Glypican 1 using gene-specific silencing with siRNA or gene overexpression using a plasmid revealed that Glypican 1 is required to protect against stiffness-mediated endothelial cell dysfunction. Consistent with this, using a model of age-mediated stiffness, older mice exhibited a reduced expression of Glypican 1 and enhanced endothelial cell dysfunction compared to young mice. Glypican 1 gene deletion in knockout mice (GPC1-/-) exacerbated endothelial dysfunction in young mice, which normally had high endothelial expression, but not in old mice that normally expressed low levels. Endothelial cell dysfunction was exacerbated in young, but not aged, Glypican 1 knockout mice (GPC1-/-).

conclusionArterial stiffness promotes EC dysfunction and vascular disease at least partly through the suppression of the glycocalyx protein Glypican 1. Glypican 1 contributes to the protection against endothelial cell dysfunction and vascular disease in endothelial cells.

Indexed as

Mechanotransduction, CellularVascular StiffnessAge FactorsAnimalsCell ProliferationCells, CulturedDisease Models, AnimalEpithelial-Mesenchymal TransitionGlycocalyxGlypicansHumansHuman Umbilical Vein Endothelial CellsInflammation MediatorsMiceMice, KnockoutRatsGlypicansGPC1 protein, humanGpc1 protein, mouseInflammation MediatorsArterial stiffnessEndothelial cell dysfunctionGlycocalyxVascular disease

Identifiers

PMID32647868
PMCPMC8152694
OpenAlexW3041701418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.